Why did you opt for the Behringwerke site?
It’s very clear to us: we need to expand our production capacities as quickly as possible – it is, of course, perfect when you find a site that is already fully equipped and has 300 highly qualified employees. We can move in here immediately, the infrastructure is excellent, and there are additional expansion opportunities at the Behringwerke site. All of this is ideal for us. Add to this the historical background of the site – we wish to continue the history of the site, which was originally founded by Emil von Behring, who helped millions of people worldwide with his developments.
What are the other arguments in favour of the Behringwerke site?
There are excellent transport connections from here. You can get to Frankfurt Airport in an hour, which is critical for distribution. And it is only an hour and a half to our headquarters in Mainz, which is important for technology and staff transfer.
“We wish to start production here in Marburg at the start of 2021, with 250 million doses planned in the first half of 2021.”
Prof. Dr. Ugur Sahin, CEO